CNBS Cannabis ETF Announces Ability to Access MSOs via Swaps
April 20 2021 - 6:00AM
Amplify ETFs is pleased to announce the Amplify Seymour Cannabis
ETF (NYSE: CNBS) now has the ability to access Multi-State
Operators (MSOs) via swaps. The ETF recently completed both legal
and operational work in order to add portfolio exposure to this
group of companies.
“We are excited to now have access to the full plant-touching
U.S. cannabis investable universe in the CNBS portfolio at a time
when we believe the U.S. market is poised for significant growth,”
said Tim Seymour, Portfolio Manager for CNBS.“We are pleased to
expand the universe of cannabis market exposure within CNBS,” said
Amplify CEO Christian Magoon. “The increase in portfolio
flexibility for Tim going forward should further equip CNBS to
continue to be the premier way for investors to obtain diversified
and professionally-managed exposure to the growing cannabis
sector.”
CNBS is an ETF investing in the fast-developing global cannabis
industry. The Fund is managed by Tim Seymour, a recognized voice
and experienced investor in the cannabis space.
Investors can learn more at https://amplifyetfs.com/cnbs.
Also, Tim Seymour provides his thoughts and insights on the
cannabis sector in a weekly audio commentary. Listen and subscribe
here: http://bit.ly/345EKxP
About Amplify ETFs
Amplify ETFs, sponsored by Amplify Investments, has over $4.8
billion in assets across its suite of ETFs (as of 4/15/2021).
Amplify believes the ETF structure empowers investors through
efficiency, transparency and flexibility. Amplify ETFs deliver
expanded investment opportunities for investors seeking growth,
income, and managed-risk strategies.
Sales Contact:Amplify
ETFs855-267-3837info@amplifyetfs.comorMedia
Contact:Gregory FCA for Amplify ETFsKerry
Davis610-228-2098amplifyetfs@gregoryfca.com
CNBS Performance Quarter End as of 3/31/2021 |
Fund Inception Date: 7/23/2019 |
Cumulative (%) |
Annualized (%) |
|
1 Mo. |
3 Mo. |
6 Mo. |
YTD |
SinceInception |
1 Yr. |
SinceInception |
Fund NAV |
-4.18 |
% |
66.14 |
% |
158.73 |
% |
66.14 |
% |
18.51 |
% |
232.80 |
% |
10.55 |
% |
Closing Price |
-3.55 |
% |
66.48 |
% |
159.72 |
% |
66.48 |
% |
18.93 |
% |
233.61 |
% |
10.78 |
% |
The performance data quoted represents past performance.
Past performance does not guarantee future results. The investment
return and principal value of an investment will fluctuate so that
an investor's shares, when sold or redeemed, may be worth more or
less than their original cost and current performance may be lower
or higher than the performance quoted. Short-term performance, in
particular, is not a good indication of the fund’s future
performance, and an investment should not be made based solely on
returns. For performance data current to the most recent month-end
please call 855-267-3837 or visit
https://amplifyetfs.com/cnbs. Brokerage
commissions will reduce returns. The Fund’s gross expense ratio is
5.61%, with a 4.86% fee waiver1
that makes the net expense ratio 0.75%.
1Pursuant to an agreement with the Fund, Amplify Investments LLC
has agreed to reduce its management fee and effectively reimburse
any acquired fund fees incurred by the Fund in an amount that
limits the Fund’s “Total Annual Fund Operating Expenses” (excluding
taxes, interest, all brokerage commissions, other normal charges
incident to the purchase and sale of portfolio securities,
distribution and service fees payable pursuant to a Rule 12b-1
plan, and other extraordinary expenses) to not more than 0.75% of
the daily net assets of the Fund until March 1, 2022.
Carefully consider the Fund’s investment objectives,
risk factors, charges and expenses before investing. This and
additional information can be found in the Fund’s statutory and
summary prospectus, which may be obtained by calling 855-267-3837
or by visiting AmplifyETFs.com.
Read the prospectus carefully before investing.
Investing involves risk, including the possible loss of
principal. Shares of any ETF are bought and sold at market price
(not NAV), may trade at a discount or premium to NAV and are not
individually redeemed from the Fund. The Fund's return may not
match or achieve a high degree of correlation with the return of
the underlying Index.
The Fund is subject to management risk because it is an actively
managed. Companies involved in the cannabis industry face
competition, may have limited access to the services of banks, may
have substantial burdens on company resources due to litigation,
complaints or enforcement actions, and are heavily dependent on
receiving necessary permits and authorizations to engage in medical
cannabis research or to otherwise cultivate, possess or distribute
cannabis. The possession and use of cannabis, even for medical
purposes, is illegal under federal and certain states’ laws, which
may negatively impact the value of the Fund’s investments.
Securities issued by non-U.S. companies present risks beyond those
of securities of U.S. issuers.
Many of the companies in which the Fund will invest are engaged
in other lines of business unrelated to cannabis and these lines of
business could adversely affect their operating results. Cannabis
is a Schedule I controlled substance under the Controlled
Substances Act (“CSA”), meaning that it has a high potential for
abuse, has no currently “accepted medical use” in the U.S., lacks
accepted safety for use under medical supervision, and may not be
prescribed, marketed or sold in the U.S. Small and/or
mid-capitalization companies may be more vulnerable to adverse
general market or economic developments, and their securities may
be less liquid and may experience greater price volatility than
larger, more established companies as a result of several factors,
including limited trading volumes, products or financial resources,
management inexperience and less publicly available information.
The Fund is non-diversified, which can cause greater share price
fluctuation.
Amplify Investments LLC is the Investment Adviser to the Fund,
and Penserra Capital Management, LLC serves as the Investment
Sub-Adviser.
Amplify ETFs are distributed by Foreside Fund Services, LLC.
Amplify Seymour Cannabis... (AMEX:CNBS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Amplify Seymour Cannabis... (AMEX:CNBS)
Historical Stock Chart
From Dec 2023 to Dec 2024